Matches in Wikidata for { <http://www.wikidata.org/entity/Q65375231> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65375231 description "clinical trial" @default.
- Q65375231 description "ensayu clínicu" @default.
- Q65375231 description "klinisch onderzoek" @default.
- Q65375231 description "клінічне випробування" @default.
- Q65375231 name "Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease" @default.
- Q65375231 name "Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease" @default.
- Q65375231 type Item @default.
- Q65375231 label "Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease" @default.
- Q65375231 label "Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease" @default.
- Q65375231 prefLabel "Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease" @default.
- Q65375231 prefLabel "Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease" @default.
- Q65375231 P1132 Q65375231-E308A7F8-55B0-45FD-A8A3-0FCD5C908DEB @default.
- Q65375231 P1476 Q65375231-FCB5318C-B32F-40CA-B859-C748E4ABBD21 @default.
- Q65375231 P2899 Q65375231-79BEBCC0-0041-45A2-8BA7-6AF861C0EAAB @default.
- Q65375231 P3098 Q65375231-C86D2FEC-2A33-48AF-ABA1-5F1128C3CF07 @default.
- Q65375231 P31 Q65375231-37FE5882-9E34-4B23-A3CB-2F8DB369B365 @default.
- Q65375231 P4135 Q65375231-4014111F-F2DF-4D23-B48A-77FA9B93F4F1 @default.
- Q65375231 P580 Q65375231-D2FB4A68-6837-45EC-8E8F-332A82113F36 @default.
- Q65375231 P582 Q65375231-5EA2538B-CD2D-4E8F-AA8A-64F87868335B @default.
- Q65375231 P6099 Q65375231-13734395-15C6-4657-A7E9-3D4A8E56CE31 @default.
- Q65375231 P6099 Q65375231-49479E7C-1406-4711-B07E-6B2EBE94891E @default.
- Q65375231 P6153 Q65375231-D89A61A5-34A4-4610-AF4B-D03692F709E8 @default.
- Q65375231 P8363 Q65375231-96EAFDD6-D259-41AD-9778-11B2B0FD25FF @default.
- Q65375231 P1132 "+390" @default.
- Q65375231 P1476 "A Multi-Center, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, Study to Evaluate the Safety and Efficacy of Huperzine A Sustained-Release Tablets in Patients With Mild to Moderate Alzheimer's Disease" @default.
- Q65375231 P2899 "+50" @default.
- Q65375231 P3098 "NCT01282619" @default.
- Q65375231 P31 Q30612 @default.
- Q65375231 P4135 "+85" @default.
- Q65375231 P580 "2010-05-01T00:00:00Z" @default.
- Q65375231 P582 "2012-06-01T00:00:00Z" @default.
- Q65375231 P6099 Q42824440 @default.
- Q65375231 P6099 Q42824827 @default.
- Q65375231 P6153 Q7488482 @default.
- Q65375231 P8363 Q78089383 @default.